WO2004015078A3 - Procedes et substances se rapportant a de nouveaux polypeptides et polynucleotides de type regulateur de croissance - Google Patents

Procedes et substances se rapportant a de nouveaux polypeptides et polynucleotides de type regulateur de croissance Download PDF

Info

Publication number
WO2004015078A3
WO2004015078A3 PCT/US2003/024922 US0324922W WO2004015078A3 WO 2004015078 A3 WO2004015078 A3 WO 2004015078A3 US 0324922 W US0324922 W US 0324922W WO 2004015078 A3 WO2004015078 A3 WO 2004015078A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides
polypeptides
growth regulatory
methods
novel growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/024922
Other languages
English (en)
Other versions
WO2004015078A2 (fr
Inventor
Nancy K Mize
Bryan Boyle
John E Ford
Matthew C Arterburn
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Yong Song
Michael Sjaastad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/216,038 external-priority patent/US20030124573A1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Priority to AU2003259696A priority Critical patent/AU2003259696A1/en
Publication of WO2004015078A2 publication Critical patent/WO2004015078A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004015078A3 publication Critical patent/WO2004015078A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des nouveaux polynucléotides, les polypeptides codés par ces polynucléotides, et des mutants ou des variants de ceux-ci, correspondant à un nouveau polypeptide de type régulateur de croissance humain. Ces polynucléotides comprennent des séquences d'acide nucléique isolées à partir de banques d'ADNc dérivées du thymus humain. D'autres aspects de l'invention comprennent des vecteurs contenant les polynucléotides décrits, des procédés permettant de produire de nouveaux polypeptides de type régulateurs de croissance humain, ainsi que des anticorps spécifiques contre ces polypeptides.
PCT/US2003/024922 2002-08-08 2003-08-06 Procedes et substances se rapportant a de nouveaux polypeptides et polynucleotides de type regulateur de croissance Ceased WO2004015078A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003259696A AU2003259696A1 (en) 2002-08-08 2003-08-06 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/216,038 2002-08-08
US10/216,038 US20030124573A1 (en) 2000-01-25 2002-08-08 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
US31183002A 2002-12-17 2002-12-17
US10/311,830 2002-12-17

Publications (2)

Publication Number Publication Date
WO2004015078A2 WO2004015078A2 (fr) 2004-02-19
WO2004015078A3 true WO2004015078A3 (fr) 2005-09-15

Family

ID=31720174

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024922 Ceased WO2004015078A2 (fr) 2002-08-08 2003-08-06 Procedes et substances se rapportant a de nouveaux polypeptides et polynucleotides de type regulateur de croissance

Country Status (2)

Country Link
AU (1) AU2003259696A1 (fr)
WO (1) WO2004015078A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201502398RA (en) * 2010-04-27 2015-05-28 Scil Technology Gmbh Stable MIA/CD-RAP formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001002564A1 (fr) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Nouveau polypeptide et adn de ce polypeptide
JP2001069994A (ja) * 1999-06-30 2001-03-21 Takeda Chem Ind Ltd 新規ポリペプチドおよびそのｄｎａ

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001002564A1 (fr) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Nouveau polypeptide et adn de ce polypeptide
JP2001069994A (ja) * 1999-06-30 2001-03-21 Takeda Chem Ind Ltd 新規ポリペプチドおよびそのｄｎａ

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 26 December 2000 (2000-12-26), COHEN-SALMON ET AL: "Homo Sapiens Fibrocyte-derived Protein (FDP)mRNA.", XP002990570, Database accession no. (AF243505) *
DATABASE GENBANK [online] 27 August 2000 (2000-08-27), ITO ET AL: "Novel Polypeptide and its DNA.", XP002990568, Database accession no. (BD093121) *
DATABASE GENBANK [online] 29 January 2001 (2001-01-29), RENDTORFF ET AL: "Homo Sapiens mRNA for Meloma Inhibitiry Activity like Protein.", XP002990569, Database accession no. (AJ42552) *
DATABASE GENBANK [online] 31 January 2002 (2002-01-31), ITO ET AL: "Novel Polypeptide and DNA thereof.", XP002990567, Database accession no. (BD010820) *
DATABASE GENBANK [online] 6 July 2000 (2000-07-06), COHEN-SALMON ET AL: "Ho,a Sapiens Otoraplin(OTOR)mRNA.", XP002990571, Database accession no. (AF233261) *
GENOMICS., vol. 66, no. 3, 2000, pages 242 - 248 *
GENOMICS., vol. 71, no. 1, 2001, pages 40 - 52 *
J.BIOL.CHEM., vol. 275, no. 51, 2000, pages 40036 - 40041 *

Also Published As

Publication number Publication date
AU2003259696A1 (en) 2004-02-25
AU2003259696A8 (en) 2004-02-25
WO2004015078A2 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
WO2001088092A3 (fr) Procedes et materiaux relatifs aux polypeptides et polynucleotides du type facteur des cellules souches (du type fcs)
EP1440981A3 (fr) ADN complementaire humaine de pleine longueur
EP1308459A3 (fr) Séquences d'ADN complementaires pleine longueur
WO2001077169A3 (fr) Methodes et materiaux relatifs a de nouveaux polypeptides et polynucleotides du type facteur de croissance des cellules-souches
CA2318030A1 (fr) Adn et polypeptides acpl
CA2343715A1 (fr) Sequence codante pour un nouveau facteur de differenciation de la croissance d'origine humaine et polypeptide code par cette sequence d'adn, et methode de production correspondante
WO2001055336A3 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
WO2001053454A3 (fr) Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
AU2002332767A1 (en) Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
EP1447413A3 (fr) ADN complementaire humaine de pleine longueur
WO2001055335A3 (fr) Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)
WO2001053500A8 (fr) Procedes et substances relatifs a des polypeptides de type facteur de croissance de cellules souches et a des polynucleotides
WO2005091777A3 (fr) Procedes et matieres associes aux polypeptides de facteur de croissance semblable a l'insuline (igfl) et polynucleotides
WO2004007672A3 (fr) Procede et materiaux se rapportant a de nouveaux polypeptides et polynucleotides
EP1574520A3 (fr) Polypeptides et polynucléotides ressemblant à la molécule de guidage neuronale ainsi que méthodes et matériaux dérivés
WO2004015078A3 (fr) Procedes et substances se rapportant a de nouveaux polypeptides et polynucleotides de type regulateur de croissance
WO2000004041A3 (fr) Procedes et materiaux associes a de nouveaux polypeptides semblables a cd39
WO2001075064A3 (fr) Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline
WO2003014703A3 (fr) Acides nucleiques, polypeptides, polymorphismes nucleotidiques simples et techniques d'utilisation de ceux-ci
WO2001055332A3 (fr) Methodes et materiaux relatifs a de nouveaux polypeptides et polynucleotides de type regulateur de croissance
WO2001053456A3 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
WO2004078918A3 (fr) Materiel et methodes de traitement et de diagnostic utilisant le ciblage de cellules exprimant les polypeptides dcal-hy
WO2003040326A3 (fr) Polypeptides et polynucleotides de type prokineticine, procedes et materiaux associes
EP0801133A3 (fr) Lyases de hydroxy-peroxyde
WO2003048326A3 (fr) Procedes et matieres associes a de nouveaux polypeptides et polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP